Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Orange Book Policing May Increase, US FDA's Gottlieb Says

Jan 10 2019

• By Derrick Gingery

Patent Law Concept 3D Illustration

Related Content

FDA “Ministerial” Approach To Patent Listings Upheld By Appeals Court

Nov 03 2003

Alphapharm's Attempt To Force Listing of Celexa Patent Rejected By Court

Aug 16 2004

Gottlieb Places Drug Pricing Out Front In First Speech To US FDA Staff

May 16 2017

Are 180-Day Exclusivity Changes Moving Out Of Drug Pricing Plans?

May 10 2018

US FDA Continues Reviewing Marketing Reports, Will It Punish Scofflaws?

Aug 19 2018

Is Bloom Gone From Rosy ANDA Approvals Figures?

Nov 12 2018

Naloxone Sponsor Steps In Pricing Hole Disputing FDA's Cost Estimates

Dec 21 2018

Related Companies

Alphapharm Pty. Ltd.

Forest Laboratories, Inc.

Additional Topics

United States Generic Drugs Legal Issues Intellectual Property Regulation FDA BioPharmaceutical

More from Generics

More from Biosimilars & Generics

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window